Zurück zu Projekte

18546.1 PFLS-LS

18546.1 PFLS-LS

Zusammenfassung

Profiling of new oxytocin receptor agonists for the treatment of anxiety and autism spectrum disorders through a new microdrive-mounted optrode allowing combined electrophysiological and fMRI analyses.

Weitere Texte

Abstract

To profile newly developed oxytocin receptor agonists for anxiety and autism spectrum disorders by comparing their actions with those of endogenous oxytocin signaling in relevant brain circuits, we will construct and implement a fMRI compatible microdrive-mounted optrode that allows measurements of effects of optogenetically stimulated release of endogenous oxytocin using simultaneous fMRI scannings and electrophysiological recordings of single unit neuronal activity.

Beteiligte

Thomas Mueggler

Wirtschaftspartner

thomas.mueggler@roche.com

F. Hoffmann-La Roche Ltd Thomas Mueggler Building 73 / Grenzacherstrasse 124 4070 Basel BS CH

Ron Stoop

Kontaktperson

Ron.Stoop@unil.ch

CHUV Centre Hospitalier Universitaire Va Centre for Psychiatric Neuroscience Ron Stoop Hôpital de Cery / Route de Cery 1005 Lausanne VD CH

Projektdetails

Forschungsstelle
INNOSUISSE
Projektstatus
Abgeschlossen
Projekttyp
Forschungsprojekt
Startdatum
2015-12-31
Enddatum
2018-12-31
Bewilligte Gesamtkosten
CHF 558114.00
Sektion
20 Förderbereich Life Sciences
NABS Politikbereich
Industrielle Produktivität und Technologie

Forschungsdisziplinen

  • T115 Medical technology 100.0%